Qube Research & Technologies LTD Organovo Holdings, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$8.67 - $21.7 $142,214 - $355,945
-16,403 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$7.19 - $17.05 $130,498 - $309,457
-18,150 Reduced 52.53%
16,403 $202,000
Q3 2020

Nov 12, 2020
BUY
$6.27 - $15.8 $216,647 - $545,937
34,553 New
34,553 $273,000

Others Institutions Holding ONVO

# of Institutions
34
Shares Held
2.44M
Call Options Held
17K
Put Options Held
0
View Full List

About ORGANOVO HOLDINGS, INC.

ONVO Quotes by TradingView
  • Ticker ONVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,712,020
  • Market Cap $3.75M
  • Description
  • Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...
More about ONVO
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email